Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome
The Efficacy of Irvingia Gabonensis (Bush Mango) in the Management of Overweight, Obesity and Metabolic Syndrome in Cameroon.
Lead SponsorGateway Health Alliance
StatusCompleted No Results Posted
Indication/ConditionMetabolic Syndrome Obesity Dyslipidemia
Intervention/Treatmentirvingia gabonensis ...
The study investigated the use and efficacy of the seeds of African bush mango (Irvingia gabonensis)to control body weight, blood lipids and hormones in overweight and obese people.
To assess the effects of seeds of Irvingia gabonensis on body weight, fasting blood glucose, plasma total and LDL cholesterol in 102 overweight and obese participants.
The study was a 10 week randomized, double blind, placebo controlled design. participants were randomly divided into 2 groups of 51 participants each. Group 1 was the placebo group, while Group 2 was the active group. Each group received 2 daily doses of 125 mg (before meals) of either placebo or Irvingia gabonensis.
Weight as well as fasting blood was taken at baseline and at 4, 8 and 10 weeks. No major detary changes or exercises were suggested during the study period.
Comparison of 250 mg per day of Irvingia gabonensis to placebo
Inclusion Criteria: BMI>26 Exclusion Criteria: Diabetics Pregnant and lactating Participating in any other weight reducing program Smokers